Trial of Atezolizumab and Bevacizumab With SRF388 or Placebo in Patients With Hepatocellular Carcinoma
Coherus Oncology, Inc.
Coherus Oncology, Inc.
Centre Oscar Lambret
National Institutes of Health Clinical Center (CC)
NeoImmuneTech
Johns Hopkins University
Lokon Pharma AB
University of California, San Diego
Dartmouth-Hitchcock Medical Center
National Institutes of Health Clinical Center (CC)
Aalborg University Hospital
Universidad Complutense de Madrid
Wake Forest University Health Sciences
National Institutes of Health Clinical Center (CC)
Centre Hospitalier Universitaire de Besancon
University Hospital, Lille
AIDS Malignancy Consortium
City of Hope Medical Center
Hospices Civils de Lyon
Institut National de la Santé Et de la Recherche Médicale, France
UNICANCER
Bayer
Coherus Oncology, Inc.
UNC Lineberger Comprehensive Cancer Center
Institut Bergonié
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Institutes of Health Clinical Center (CC)
Arab American University (Palestine)
Jazz Pharmaceuticals
Amgen
Sahlgrenska University Hospital
National Institutes of Health Clinical Center (CC)
Duke University
Washington University School of Medicine
Palleon Pharmaceuticals, Inc.
Novartis
University of California, San Diego
Trishula Therapeutics, Inc.
PharmaMar
Izmir Bakircay University
Trishula Therapeutics, Inc.
OncoAtlas LLC
Azienda USL Reggio Emilia - IRCCS
Azienda USL Reggio Emilia - IRCCS
Royal Surrey County Hospital NHS Foundation Trust
Nuvation Bio Inc.
UNICANCER
PhytoHealth Corporation
Puerta de Hierro University Hospital
Hoffmann-La Roche
Pfizer